PM Modi visits Bharat Biotech's vaccine manufacturing facility in Hyderabad

Covaxin, being developed by Bharat Biotech in collaboration with the
Indian Council of Medical Research and National Institute of Virology,
is now undergoing phase-3 trials. The Phase-3 trials involve 26,000
volunteers across India, conducted in partnership with ICMR.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pm-modi-visits-bharat-biotechs-vaccine-manufacturing-facility-in-hyderabad/articleshow/79462953.cms

Comments

Popular posts from this blog

NISER PhD Program Admission 2020-21 (Winter Session)

Are hospitals prescribing the more expensive remdesivir instead of cheaper alternatives?

Data Analyst Jobs – Life Sciences Apply at Cognizant